Elixinol Wellness (ELLXF) Financial Statements
Elixinol Wellness Financial Overview
Elixinol Wellness's market cap is currently $1.92M. The company's EPS TTM is $-0.01; its P/E ratio is -0.59; Elixinol Wellness is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 15.50M | $ 14.96M | $ 8.27M | $ 7.05M | $ 9.34M |
| Gross Profit | $ 752.00K | $ 5.36M | $ -1.80M | $ -3.27M | $ -6.25M |
| Operating Income | $ -4.98M | $ -3.47M | $ -6.43M | $ -10.00M | $ -15.61M |
| EBITDA | $ -4.11M | $ -4.01M | $ -6.81M | $ -9.28M | $ -15.51M |
| Net Income | $ -5.50M | $ -1.72M | $ -7.51M | $ -10.57M | $ -17.02M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.41M | $ 1.08M | $ 708.00K | $ 2.86M | $ 12.65M |
| Total Assets | $ 15.96M | $ 18.45M | $ 11.71M | $ 13.48M | $ 25.33M |
| Total Debt | $ 3.73M | $ 1.94M | $ 1.26M | $ 1.83M | $ 2.71M |
| Net Debt | $ 2.32M | $ 862.00K | $ 554.00K | $ -1.03M | $ -10.00M |
| Total Liabilities | $ 8.51M | $ 8.42M | $ 5.25M | $ 4.33M | $ 6.25M |
| Stockholders' Equity | $ 7.45M | $ 10.03M | $ 6.46M | $ 9.16M | $ 19.08M |
| Cash Flow | |||||
| Free Cash Flow | $ -3.28M | $ -3.53M | $ -2.77M | $ -8.16M | $ -14.36M |
| Operating Cash Flow | $ -3.21M | $ -3.47M | $ -2.76M | $ -8.15M | $ -14.07M |
| Investing Cash Flow | $ -216.00K | $ -66.00K | $ -1.04M | $ -869.00K | $ 172.00K |
| Financing Cash Flow | $ 3.65M | $ 3.92M | $ 1.61M | $ -757.00K | $ -1.16M |
Currency in AUD